Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States by Christoph Wanner, Johannes Schuchhardt, Chris Bauer, Meike Brinker, Frank Kleinjung, Tatsiana Vaitsiakhovich

Get full text

WCN25-288 EFFECT OF FINERENONE TREATMENT DISCONTINUATION ON KIDNEY AND CV OUTCOMES IN PATIENTS WITH CKD AND T2D: A FIDELITY SUBANALYSIS by Stefan Anker, Bertram Pitt, Peter Rossing, Luis Ruilope, Christiane Ahlers, Youssef Farag, Marc Lambelet, Meike Brinker, Katja Rohwedder, Zihe Zheng, Gerasimos Filippatos

Get full text

WCN25-662 EFFICACY AND SAFETY OF FINERENONE IN PATIENTS WITH NEPHRECTOMY: A FIDELITY SUBANALYSIS by Jair Munoz Mendoza, Matthew Weir, Stefan D. Anker, Gerasimos Filippatos, Peter Rossing, Christiane Ahlers, Meike Brinker, Samuel T. Fatoba, Andrea Horvat-Broecker, Katja Rohwedder, Alessia Fornoni

Get full text

WCN24-432 FINERENONE IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: A FIDELITY ANALYSIS by Ping Li, Yu An, Hongguang Zheng, Weiping Lu, Zhaohui Mo, Xu Xudong, Lu Yibing, Chaoqing Wu, Jingyuan Xie, Nanwei Tong, Fang Liu, Qinkai Chen, Meike Brinker, Dalong Zhu, Zhihong Liu

Get full text

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials by George L Bakris, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Shweta Bansal, Maria E F Canziani, Rita Birne, Luis M Ruilope, Alfredo E Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker

Get full text

Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes by Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Andrew J.S. Coats, Stephan vonHaehling, Piotr Ponikowski, Giuseppe M.C. Rosano, Meike Brinker, Alfredo E. Farjat, Luke Roberts, Bertram Pitt, the FIDELIO‐DKD and FIGARO‐DKD investigators

Get full text